Advanced Search

 

Study ID Status Title Patient Level Data
SUM40029 Completed Pharmacokinetics and user acceptability of Intraject sumatriptan vs GW auto-injector (Subject, Self or Statdose) in migraine patients outside of an attack.
SUM40031 Completed A randomised double-blind, double-dummy, single-attack, parallel group study to compare the speed of onset of sumatriptan nasal spray (20mg) with rizatriptan wafer (10mg) in the acute treatment of migraine.
SUM40036 Completed A study of the pharmacokinetics and bioequivalence of the Japanese and GWUK market formulations of sumatriptan succinate performed in Japanese and Caucasian populations.
SUM40056 Completed An open-label study to rechallenge patients who had previously experienced an adverse event involving discomfort or pain in the chest or throat following sumatriptan administration (SC or oral). Rechallenge during a migraine attack with subcutaneous sumatriptan 6mg.
SUM40058 Completed A double-blind, randomised, placebo controlled, crossover study to assess return of headache in patients treated with 6mg subcutaneous sumatriptan early or late in a migraine attack; with optional open-label doses to assess pattern of use of sumatriptan over the subsequent 72 hour period.
SUM40083 Completed A double-blind, placebo-controlled, parallel group study to evaluate the efficacy of subcutaneous GR43175C (6mg & optional 6mg) in the acute treatment of menstrual migraine – with optional open follow-up treatment: Phase I.
SUM40083_1 Completed A double-blind, placebo-controlled, parallel group study to evaluate the efficacy of subcutaneous GR43175C (6mg & optional 6mg) in the acute treatment of menstrual migraine – with optional open follow-up treatment. Phase II.
SUM40090 Completed The use of oral sumatriptan on compassionate grounds for the acute treatment of migraine in adolescent patients (ages 12 to 17).
SUM40126 Completed An open design, multiple treatment study to evaluate subcutaneous sumatriptan (6mg) in the acute treatment of cluster headache attacks during a 3-month period.
SUM40128 Completed The acute treatment of cluster headache with subcutaneous GR43175C (6mg and 12mg) – a double-blind, placebo-controlled, dose-comparison, crossover study.
SUM40130 Completed Evaluation of a combined regimen of subcutaneous and oral GR43175C in the prevention of migraine recurrence.
SUM40135 Completed A double-blind, placebo-controlled, parallel-group study of a second 100mg oral dose of GR43175C in the acute treatment of a migraine attack and of a further 100mg dose in treating headache recurrence.
SUM40157 Completed A double-blind, placebo-controlled, crossover-designed study, to evaluate the efficacy of oral sumatriptan (100mg) in the acute treatment of perimenstrual migraine attacks.
SUM40204 Completed Imitrex® Post-Marketing Surveillance Study.
SUM40218 Completed A double blind study to compare acute sumatriptan with Migril in the treatment of migraine.
SUM40220 Completed A single-blind study to rechallenge patients who had previously experienced an adverse event involving discomfort or pain in the chest or throat following sumatriptan administration (SC or oral). Rechallenge outside of a migraine attack with subcutaneous sumatriptan 6mg.
SUM40229 Completed A randomised, multicentre, double-blind, double-dummy, parallel-group study to compare the efficacy and safety of subcutaneous sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine.
SUM40241 Completed A study to investigate the effects of subcutaneous sumatriptan on cardiac haemodynamics in patients with existing or suspected coronary artery disease.
SUM40252 Completed An open, randomized, three-way crossover study in healthy subjects to evaluate the bioequivalence and taste acceptability of two different 20mg/100?L sumatriptan nasal spray formulations compared to the current 20mg/100?L sumatriptan nasal spray market formulation following single dose administr ...
SUM40254 Completed A study to investigate the single dose pharmacokinetics of sumatriptan nasal spray in pediatric subjects outside a migraine attack
SUM40255 Completed Open, pilot study to evaluate the efficacy, tolerability and safety of a combination of sumatriptan oral (50mg) + oral metoclopramide (10mg) + oral aspirin (900mg) in the treatment of a single migraine attack in patients not usually pain free during previous attacks, with the following molecules ...
SUM40257 Completed A randomised, multi-centre, open-label, crossover study to evaluate patient preference for sumatriptan 50mg and 100mg, naratriptan 2.5mg, rizatriptan 10mg and zolmitriptan 2.5mg tablets in the acute treatment of migraine.
SUM40260 Completed Patient Preference for and Satisfaction With Migraine Therapy: IMITREX® Tablets Versus Pre-Study Non-Triptan Therapy.Imitrex is a registered trademark of GlaxoSmithKline.
SUM40265 Completed A prospective multicentre study investigating the association between disability (as measured by the headache impact test, HIT-6) and IHS migraine classification (as determined by expert panel diary review) and to observe any changes in HIT-6 score following treatment with oral sumatriptan 50mg.
SUM40272 Completed An open-label, randomized, cross-over study to investigate the potential pharmacokinetic interaction of sumatriptan and clarithromycin when co-administered to healthy volunteers.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.